GenFleet Therapeutics Issues 13.60 Million New H Shares via HK$34.69 Placing, Lifts Total Issued Shares to 351.63 Million

Bulletin Express08-05

GenFleet Therapeutics (Shanghai) Inc. completed the allotment of 13.60 million new H shares on 17 July 2026 at HK$34.69 per share under a general mandate, according to the company’s Monthly Return for Equity Issuer filed with Hong Kong Exchanges and Clearing.

The placement increased the company’s issued H-share count to 351.63 million, up from 338.03 million at the end of June 2026. Total issued share capital—including 32.34 million unlisted domestic shares—now stands at 383.97 million shares.

Public-float compliance is maintained, with the free-float ratio confirmed at or above the 19.86 percent threshold prescribed at listing.

No treasury shares, share options, warrants, convertibles, or other equity instruments were outstanding or transacted during the reporting month.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment